I would certainly hope that they could enlist way faster this time around given they now have past history at the Australian sites at least. Korean sites should be quicker as well otherwise why go there?
Given the monthly burn rate of being a public company and the headcount it would be far more efficient to aim/design for last patient in by end July 24 IMO.
News: ATX Amplia Therapeutics Says Approval From Korean Regulator, page-14
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.19M | |||
| Open | High | Low | Value | Volume |
| 6.8¢ | 6.8¢ | 6.2¢ | $31.83K | 481.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 33151 | 6.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.7¢ | 25131 | 1 |
View Market Depth
| Last trade - 15.10pm 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.7¢ |
Change
0.000 ( 0.75 %) |
||||
| Open | High | Low | Volume | ||
| 6.8¢ | 6.8¢ | 6.3¢ | 182250 | ||
| Last updated 14.41pm 18/06/2024 ? | |||||
| ATX (ASX) Chart |